Skip to content
S4169Senate2021-2022 Session

Expand Medical Marijuana Access

Official title

“Relates to medical marihuana”

Sponsor Diane J. SavinoSD-23Affects Health
Status
In Senate Committee
Health
Impact
8/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill expands New York's medical marijuana program by increasing dispensaries, adding qualifying conditions, improving access, enabling research, and promoting social equity.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Expand Medical Marijuana Access

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Diane J. Savino

Senator · Senate District 23

Chair, Internet And Technology

No co-sponsors yet.

History

  1. Referred to health
  2. Referred to health

Full text

12 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

4169

2021-2022 Regular Sessions

IN SENATE

February 2, 2021

Introduced by Sen. SAVINO -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to medical marihuana; and to amend chapter 90 of the laws of 2014, amending the public health law and other laws relating to medical use of marihuana, in relation to the effectiveness thereof

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Legislative intent. The compassionate care act provides patients with necessary access to medical marihuana. While the program has provided relief to numerous patients, several improvements are necessary. Specifically, the program has suffered from overly restrictive requirements regarding market participation and product regulation. Currently, the program restricts access by only permitting one dispensary for every 500,000 New Yorkers - leaving both urban and rural communities drastically underserved. This act will improve the existing program by providing opportunities for social equity applicants to participate in the marketplace in a manner that more accurately represents the demographics of the state. Social equity applicants will include applicants from communities disproportionately impacted by cannabis law enforcement. This act will also provide necessary flexibility for market participants to offer products that are more accessible and affordable to some of New York's most vulnerable citizens. Specifically, current restrictions on the sale of whole flower result in medical products that are cost-prohibitive to many. Moreover, this act will provide greater access to individuals who are unable to enroll in the program including those with Alzheimer's disease and who have been diagnosed with autism spectrum disorder. Much like the addition of chronic pain as a qualifying condition, this will allow medical practitioners to recommend an alternative to addictive opiates. These changes will give New Yorkers access to quality care they deserve.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD00363-03-1

S. 4169 2

§ 2. Subdivisions 1, 5, 7 and 12 of section 3360 of the public health law, subdivisions 1, 5, 7 and 12 as added by chapter 90 of the laws of 2014, paragraph (a) of subdivision 7 as amended by chapter 273 of the laws of 2018, are amended and three new subdivisions 5-a, 5-b and 19 are added to read as follows:

1. "Certified medical use" means the acquisition, possession, use, or, transportation of medical marihuana by a certified patient, or the acquisition, possession, delivery, transportation or administration of medical marihuana by a designated caregiver, for use as part of the treatment of the patient's [serious] condition, as authorized in a certification under this title including enabling the patient to tolerate treatment for the [serious] condition. [A certified medical use does not include smoking.]

5. "Designated caregiver" means the individual or caregiver facility designated by a certified patient in a registry application. A certified patient may designate up to two designated caregivers, not counting a designated caregiver facility or designated caregiver facility employee.

5-a. "Designated caregiver facility" means an entity that registers with the commissioner to assist one or more certified patients with the acquisition, possession, delivery, transportation or administration of medical marihuana and is: a general hospital or residential health care facility operating under article twenty-eight of this chapter; an adult care facility operating under title two of article seven of the social services law; a community mental health residence established under section 41.44 of the mental hygiene law; a hospital operating under section 7.17 of the mental hygiene law; a mental hygiene facility operating under article thirty-one of the mental hygiene law; an inpatient or residential treatment program certified under article thirty-two of the mental hygiene law; a residential facility for the care and treatment of persons with developmental disabilities operating under article sixteen of the mental hygiene law; a residential treatment facility for children and youth operating under article thirty-one of the mental hygiene law; a public school or private school operating under the education law; a research institution with an internal review board; a medical marihuana research program licensed under section thirty-three hundred sixty-four-a of this title; or any other facility as determined by the commissioner in regulation.

5-b. "Designated caregiver facility employee" means an employee of a designated caregiver facility.

7. (a) ["Serious condition"] "Condition" means:

(i) having one of the following [severe debilitating or life-threatening] conditions: cancer, positive status for human immunodeficiency virus or acquired immune deficiency syndrome, amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis, damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, epilepsy, inflammatory bowel disease, neuropathies, Huntington's disease, post-traumatic stress disorder, pain that degrades health and functional capability where the use of medical marihuana is an alternative to opioid use, substance use disorder, Alzheimer's, muscular dystrophy, dystonia, rheumatoid arthritis, autism, or [as added by the commissioner; and

(ii) any of the following conditions where it is clinically associated with, or a complication of, a condition under this paragraph or its treatment: cachexia or wasting syndrome; severe or chronic pain; severe nausea; seizures; severe or persistent muscle spasms; or such conditions as are added by the commissioner.

S. 4169 3

(b) No later than eighteen months from the effective date of this section, the commissioner shall determine whether to add the following serious conditions: Alzheimer's, muscular dystrophy, dystonia, posttraumatic stress disorder and rheumatoid arthritis] any other condition certified by the practitioner.

12. "Practitioner" means a practitioner who (i) [is a physician licensed by New York state and practicing within the state,] is authorized to prescribe controlled substances within the state; (ii) [who] by training or experience is qualified to treat a [serious] condition as defined in subdivision seven of this section; and (iii) [has completed a two to four hour course as determined by the commissioner in regulation and registered with the department; provided however, a registration shall not be denied without cause. Such course may count toward board certification requirements. The commissioner shall consider the inclusion of nurse practitioners under this title based upon considerations including access and availability. After such consideration the commissioner is authorized to deem nurse practitioners as practitioners under this title] completes, at a minimum, a two hour course as determined by the commissioner. A person's status as a practitioner under this title is deemed to be a "license" for purposes of section thirty-three hundred ninety of this article.

19. "Medical marihuana research program" means a medical marihuana research program licensed under section thirty-three hundred sixty-four-a of this title.

§ 3. Subdivisions 1, 2, and 9 of section 3361 of the public health law, subdivisions 1 and 2 as added by chapter 90 of the laws of 2014 and subdivision 9 as added by chapter 416 of the laws of 2015, are amended to read as follows:

1. A patient certification may only be issued if: (a) a practitioner has been registered with the department to issue a certification as determined by the commissioner; (b) the patient has a [serious] condition, which shall be specified in the patient's health care record; (c) the practitioner by training or experience is qualified to treat the [serious] condition; (d) the patient is under the practitioner's continuing care for the [serious] condition; and (e) in the practitioner's professional opinion and review of past treatments, the patient is likely to receive therapeutic or palliative benefit from the primary or adjunctive treatment with medical use of marihuana for the [serious] condition.

2. The certification shall include (a) the name, date of birth and address of the patient; (b) a statement that the patient has a [serious] condition and the patient is under the practitioner's care for the [serious] condition; (c) a statement attesting that all requirements of subdivision one of this section have been satisfied; (d) the date; and (e) the name, address, federal registration number, telephone number, and the handwritten signature of the certifying practitioner. The commissioner may require by regulation that the certification shall be on a form provided by the department. The practitioner may state in the certification that, in the practitioner's professional opinion, the patient would benefit from medical marihuana only until a specified date. The practitioner may state in the certification that, in the practitioner's professional opinion, the patient is terminally ill and that the certification shall not expire until the patient dies.

9. (a) A certification may be a special certification if, in addition to the other requirements for a certification, the practitioner certifies in the certification that the patient's [serious] condition is

S. 4169 4

progressive and degenerative or that delay in the patient's certified medical use of marihuana poses a serious risk to the patient's life or health.

(b) The department shall create the form to be used for a special certification and shall make that form available to be downloaded from the department's website.

§ 4. Subdivisions 1 and 2 of section 3362 of the public health law, as added by chapter 90 of the laws of 2014, are amended and a new subdivision 3 is added to read as follows:

1. The possession, acquisition, use, delivery, transfer, transportation, or administration of medical marihuana by a certified patient or designated caregiver possessing a valid registry identification card, for certified medical use, shall be lawful under this title; provided that:

(a) the marihuana that may be possessed by a certified patient shall not exceed a [thirty] sixty day supply of the dosage as determined by the practitioner, consistent with any guidance and regulations issued by the commissioner, provided that during the last seven days of any [thirty] sixty day period, the certified patient may also possess up to such amount for the next [thirty] sixty day period;

(b) the marihuana that may be possessed by designated caregivers does not exceed the quantities referred to in paragraph (a) of this subdivision for each certified patient for whom the caregiver possesses a valid registry identification card, up to five certified patients;

(c) the marihuana that may be possessed by designated caregiver facilities does not exceed the quantities referred to in paragraph (a) of this subdivision for each certified patient under care or treatment of the facility;

(d) the form or forms of medical marihuana that may be possessed by the certified patient [or], designated caregiver, or designated caregiver facility pursuant to a certification shall be in compliance with any recommendation or limitation by the practitioner as to the form or forms of medical marihuana or dosage for the certified patient in the certification; and

[(d)] (e) the medical marihuana shall be kept in the original package in which it was dispensed under subdivision twelve of section thirtythree hundred sixty-four of this title, except for the portion removed for immediate consumption for certified medical use by the certified patient.

2. Notwithstanding subdivision one of this section:

(a) possession of medical marihuana shall not be lawful under this title if it is smoked, consumed, vaporized, or grown in a public place, regardless of the form of medical marihuana stated in the patient's certification.

(b) a [person] certified patient or designated caregiver possessing medical marihuana under this title shall possess his or her registry identification card at all times when in immediate possession of medical marihuana.

(c) medical marihuana may not be smoked in any place where tobacco may not be smoked under article thirteen-E of this chapter, regardless of the form of medical marihuana stated in the patient's certification.

3. The possession, acquisition, delivery, transfer, transportation, or administration of medical marihuana by a designated caregiver facility or designated caregiver facility employee shall be lawful under this title provided that:

S. 4169 5

(a) the designated caregiver facility registers with the department on a form provided by the commissioner;

(b) such possession, acquisition, delivery, transfer, transportation, or administration is on behalf of a certified patient possessing a registry identification card;

(c) the designated caregiver facility maintains a copy of the registry identification card of each certified patient for which it possesses, acquires, delivers, transfers, transports, or administers medical marihuana; and

(d) a designated caregiver facility employee shall be identified as an employee when necessary, as provided by the commissioner.

§ 5. Subdivisions 2, 3, 5, and 11 of section 3363 of the public health law, as added by chapter 90 of the laws of 2014, are amended to read as follows:

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to medical marihuana; and to amend chapter 90 of the laws of 2014, amending the public health law and other laws relating to medical use of marihuana, in relation to the effectiveness thereof

Purpose or general idea of bill

THIS BILL ADDRESSES SEVERAL PROBLEMS WITH THE MEDICAL MARIJUANA PROGRAM. THIS BILL CONSOLIDATES SEVERAL PROPOSALS FROM OTHER BILLS, AS WELL AS CHANGES TO THE MEDICAL PROGRAM PROPOSED IN THE 2019 EXECUTIVE BUDGET'S CANNABIS REGULATION AND TAXATION ACT (CRTA).

Summary of specific provisions

Section 1:

Read the full memo (1,565 words)

Legislative Intent

Section 2: Amends PHL § 3360 to:

* Expand eligible conditions to include any condition certified by the practitioner;

* Allow any practitioner otherwise authorized to prescribe controlled substances to certify patients for medical marijuana;

* Remove prohibitions on the smoking of medical marijuana; and

* Create the categories of "designated caregiver facility," "designated caregiver facility employee," and "medical marihuana research program."

Section 3: Amends PHL § 3361 to make conforming changes. Section 4: Amends PHL § 3362 to:

* Change possession limits from a 30 day to a 60 day supply;

* Authorize possession, acquisition, delivery, transfer, and adminis- tration of medical marijuana by designated caregiver facilities and their employees subject to certain requirements; and

* Prohibit smoking of medical marijuana in any place where tobacco may not be smoked under the Clean Indoor Air Act.

Section 5: Amends PHL § 3363 to:

* Remove the $50 patient application fee for registry ID cards;

* Remove patient-per-caregiver limits when the caregiver is a designated caregiver facility; and

* Make conforming changes Section 6: Amends PHL § 3364 to:

* Authorize registered organizations (ROs) to contract out ancillary functions such as shipping, construction, and security; and

* Make conforming changes Section 7: Creates a new PHL § 3364-a, "medical marihuana research licenses," to:

* Establish a medical marijuana research license for purposes of test- ing, clinical investigations, and safety and efficacy or genomic or agricultural research relating to medical marijuana; and

*Details application, licensing, and oversight process.

Section 8: Creates a new PHL § 3364-b, "registration of designated care- giver facilities," to:

* Establishes registration process for "designated caregiver facilities" among provider types defined in section 1 of the bill; and

* Details application, registration, and oversight process. Section 9: Creates a new PHL § 3364-c, "laboratory permits," to:

* Detail application, permitting, and oversight process. Section 10: Amends PHL § 3365 to:

* Increase dispensaries per RO from 4 to 8; and

* Direct the Commissioner to register additional ROs reflecting the demographics of the state. Section 11: Amends PHL § 3365-a to make conforming changes. Section 12: Amends PHL § 3369 to make conforming changes.

Section 13: Amends PHL § 3369-d to remove prior approval of medical marijuana prices; maintain requirement for ROs to document price chang- es; and maintain the commissioner's power to modify prices if necessary to maintain access.

Section 14: Immediate effective date. Amendments -

New Section 1- Legislative Intent - with focus on expanding the program for patients and business opportunities for social equity applicants.

Rest of bill is renumbered

New Section 9 - adds requirement that registered organizations estab- lishes a subsidy program to provide assistance and increase access to patients.

New Section 10 - adds outlines the social and economic equity plan

Justification

Open conditions list: There is no pharmaceutical other than medical marijuana for which the State restricts its use to a limited list of conditions. Setting a conditions list in statute takes medical decisions out of the hands of the practitioners who know their patients best and whose judgment the law respects for much more dangerous drugs. Practi- tioners also lack clarity about which conditions are actually covered. For example, the Public Health Law definition of "severe or chronic pain" is inconsistent with regulatory language for "severe debilitating pain that degrades health and functional capability."

This bill would maintain the naming of several conditions in statute for illustrative purposes, including some added in the Governor' s 2019 Cannabis Regulation and Taxation Act (CRTA), but also allows "any other condition certified by the practitioner." While the drafting is differ- ent, the effect is the same as S2058 of 2019.

Expanded practitioner list: Today, physicians, physician assistants, and nurse practitioners can certify patients. However, there are other cate- gories of practitioner outside these who are authorized to prescribe much more dangerous substances and often treat conditions for which a patient may be eligible (such as podiatrists and dentists whose treat- ments involve pain medication.) This bill expands the practitioner cate- gories to cover these groups, similar to S2056 of 2019.

Strike patient registry fees; increase supply from 30 to 60 days: Current law requires a $50 application fee for registry identification cards and limits patients to a 30-day supply. While the application fee is often waived, it presents a barrier to access that does not exist for patients with any other pharmaceutical product. Current law also limits patients to acquiring 30-day supplies at once distances, this limits access. The 2019 Executive budget proposed Cannabis Regulation and Taxa- tion Act (CRTA) included both of these changes.

Allow smoking: For some patients, smoking is the most affordable deliv- ery method and enable them to effectively limit dosage. Out of over 30 states that now have medical marijuana programs, only 4 disallow smoking as New York does. While smoking can involve respiratory or other issues, the quantities involved in medical marijuana use are very limited, and should be a matter between patient and practitioner. This legislation would protect the public by making medical marihuana smoking subject to the Clean Indoor Air Act restrictions, similar to 5490 of 2019.

Facility caregivers: Current law allows patients to designate up to two people as caregivers under the program. Caregivers are capped at five patients each. These caps have caused problems administering medical marijuana in residential facilities or hospitals where there may be more than five patients using medical marijuana for a given caregiver, or where a patient may see more than two potential caregiver personnel (e.g., nurses) on a regular basis. This bill authorizes, but does not mandate, certain facilities to become "designated care giver facili- ties," exempting them from such restrictions, similar to 52059 of 2019 and language in the CRTA. Research licenses: While there is significant research, being done overseas, medical marijuana research in the United States is limited. This bill would facilitate medical marijuana research in New York based on departmental regulations. Both 52059 of 2019 and the CRTA also authorize research licenses.

Expanded lab testing: Today, the State's Wadsworth Laboratory is the only lab authorized to test medical marijuana. As the program expands, more lab capacity is needed. Commercial labs with Drug Enforcement Agen- cy (DEA) licenses may be reluctant to test medical marijuana out of fear of endangering these DEA licenses. This bill removes the requirement that a lab which tests medical marijuana hold a DEA license and details State permitting of labs for medical marijuana testing, similar to both S2059 of 2019 and the CRTA. RO contracting: Registered organizations (R0s) are currently not allowed to contract out any part of the production and distribution processes. This is contrary to standard business practice, is inefficient and raises costs. This bill allows ROs to contract out ancillary functions, such as security or transportation, while ensuring that laws applicable to the RO for the purpose of those services would apply to the contractors as well and excluding certain services directly related to the manufacturing process (such as trim- ming). This is similar to both 52059 of 2019 and the CRTA. Increased dispensaries and ROs: Current law authorizes up to four dispensaries for each of the 10 ROs that engages in manufacturing. This places New York far below every other state medical marijuana programs for dispensary access per population. For comparison, New York has approximately 500,000 people per dispensary versus 233,000 to 1 in Illinois; 192,000 in Michigan, and 70,000 in Florida. This bill would double the number from 4 to 8 per RO. The bill also directs the commissioner to register additional ROs "reflecting the demographics of the state." While current law does authorize the registration of additional ROs, this explicit direction signals the importance of greater minority and women-owned participation in the medical marijuana program. The dispensary expansion is also found in S2059 of 2019.

Modifying price controls: Current law authorizes price setting by the commissioner and prohibits any sale not in accordance with such prices. In practice, ROs submit prices and price changes to the department for approval. Since enactment, not one price setting or proposed change has ever been rejected. But it takes weeks or even months for ROs to get approvals, during which time they either cannot roll out new products or cannot sell existing products at their new, typically lower prices (nearly all price changes are downward changes; maintains reporting of all price changes to the department; and maintains the commissioner's authority to reject or modify prices if necessary to maintain access.

Prior legislative history

2019 - S5657 -New bill - referred to Health

2020 - S5657B - reported from Health to Finance

Fiscal implications

Minimal. Minor reduction in patient registration fees ($50 each); likely revenue increase from licensing of additional ROs and fees associated with new license categories.

Effective date

Immediate.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.